WO2014026656A1 - Nanofiber structure with immobilized organic agens and the method of its preparation - Google Patents

Nanofiber structure with immobilized organic agens and the method of its preparation Download PDF

Info

Publication number
WO2014026656A1
WO2014026656A1 PCT/CZ2012/000128 CZ2012000128W WO2014026656A1 WO 2014026656 A1 WO2014026656 A1 WO 2014026656A1 CZ 2012000128 W CZ2012000128 W CZ 2012000128W WO 2014026656 A1 WO2014026656 A1 WO 2014026656A1
Authority
WO
WIPO (PCT)
Prior art keywords
agens
organic
fact
tetraalkoxysilane
nanofibers
Prior art date
Application number
PCT/CZ2012/000128
Other languages
French (fr)
Other versions
WO2014026656A8 (en
Inventor
Irena SLAMBOROVA
Veronika ZAJIKOVA
Petr EXNAR
Jarmila STUDNICKOVA
Original Assignee
Technicka Uiversita V Liberci
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Technicka Uiversita V Liberci filed Critical Technicka Uiversita V Liberci
Priority to EP12818872.9A priority Critical patent/EP2884968A1/en
Priority to US14/421,256 priority patent/US20150240411A1/en
Publication of WO2014026656A1 publication Critical patent/WO2014026656A1/en
Publication of WO2014026656A8 publication Critical patent/WO2014026656A8/en

Links

Classifications

    • DTEXTILES; PAPER
    • D06TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06MTREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
    • D06M13/00Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment
    • D06M13/50Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment with organometallic compounds; with organic compounds containing boron, silicon, selenium or tellurium atoms
    • D06M13/51Compounds with at least one carbon-metal or carbon-boron, carbon-silicon, carbon-selenium, or carbon-tellurium bond
    • D06M13/513Compounds with at least one carbon-metal or carbon-boron, carbon-silicon, carbon-selenium, or carbon-tellurium bond with at least one carbon-silicon bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A61K47/6923Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being an inorganic particle, e.g. ceramic particles, silica particles, ferrite or synsorb
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6953Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a fibre, a textile, a slab or a sheet
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51Nanocapsules; Nanoparticles
    • A61K9/5107Excipients; Inactive ingredients
    • A61K9/5115Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51Nanocapsules; Nanoparticles
    • A61K9/5192Processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0004Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing inorganic materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061Use of materials characterised by their function or physical properties
    • A61L26/0066Medicaments; Biocides
    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B35/00Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
    • C04B35/622Forming processes; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
    • C04B35/62227Forming processes; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products obtaining fibres
    • C04B35/62231Forming processes; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products obtaining fibres based on oxide ceramics
    • C04B35/6224Fibres based on silica
    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B35/00Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
    • C04B35/622Forming processes; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
    • C04B35/626Preparing or treating the powders individually or as batches ; preparing or treating macroscopic reinforcing agents for ceramic products, e.g. fibres; mechanical aspects section B
    • C04B35/628Coating the powders or the macroscopic reinforcing agents
    • C04B35/62844Coating fibres
    • DTEXTILES; PAPER
    • D01NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01DMECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
    • D01D5/00Formation of filaments, threads, or the like
    • D01D5/0007Electro-spinning
    • D01D5/0015Electro-spinning characterised by the initial state of the material
    • D01D5/003Electro-spinning characterised by the initial state of the material the material being a polymer solution or dispersion
    • DTEXTILES; PAPER
    • D01NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01FCHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F9/00Artificial filaments or the like of other substances; Manufacture thereof; Apparatus specially adapted for the manufacture of carbon filaments
    • D01F9/08Artificial filaments or the like of other substances; Manufacture thereof; Apparatus specially adapted for the manufacture of carbon filaments of inorganic material
    • DTEXTILES; PAPER
    • D06TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06MTREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
    • D06M13/00Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment
    • D06M13/322Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment with compounds containing nitrogen
    • D06M13/402Amides imides, sulfamic acids
    • D06M13/415Amides of aromatic carboxylic acids; Acylated aromatic amines
    • DTEXTILES; PAPER
    • D06TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06MTREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
    • D06M13/00Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment
    • D06M13/322Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment with compounds containing nitrogen
    • D06M13/402Amides imides, sulfamic acids
    • D06M13/418Cyclic amides, e.g. lactams; Amides of oxalic acid
    • DTEXTILES; PAPER
    • D06TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06MTREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
    • D06M16/00Biochemical treatment of fibres, threads, yarns, fabrics, or fibrous goods made from such materials, e.g. enzymatic
    • D06M16/003Biochemical treatment of fibres, threads, yarns, fabrics, or fibrous goods made from such materials, e.g. enzymatic with enzymes or microorganisms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00Materials characterised by their function or physical properties
    • A61L2400/12Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2235/00Aspects relating to ceramic starting mixtures or sintered ceramic products
    • C04B2235/02Composition of constituents of the starting material or of secondary phases of the final product
    • C04B2235/30Constituents and secondary phases not being of a fibrous nature
    • C04B2235/44Metal salt constituents or additives chosen for the nature of the anions, e.g. hydrides or acetylacetonate
    • C04B2235/441Alkoxides, e.g. methoxide, tert-butoxide
    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2235/00Aspects relating to ceramic starting mixtures or sintered ceramic products
    • C04B2235/02Composition of constituents of the starting material or of secondary phases of the final product
    • C04B2235/50Constituents or additives of the starting mixture chosen for their shape or used because of their shape or their physical appearance
    • C04B2235/52Constituents or additives characterised by their shapes
    • C04B2235/5208Fibers
    • C04B2235/5264Fibers characterised by the diameter of the fibers
    • DTEXTILES; PAPER
    • D06TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06MTREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
    • D06M2400/00Specific information on the treatment or the process itself not provided in D06M23/00-D06M23/18
    • D06M2400/01Creating covalent bondings between the treating agent and the fibre
    • DTEXTILES; PAPER
    • D10INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10BINDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10B2101/00Inorganic fibres
    • D10B2101/02Inorganic fibres based on oxides or oxide ceramics, e.g. silicates

Definitions

  • Nanofiber structure with immobilized organic agens and the method of its preparation Nanofiber structure with immobilized organic agens and the method of its preparation
  • the invention concerns a nanofiber structure with immobiiized organic agens.
  • the invention also concerns a method of preparation of the nanofiber structure with immobilized organic agens.
  • the employed organic agens usually cannot be recovered from the application area, e.g. for further use, and a new quantity of the functional organic agens needs to be added into the next production batch. This, however, significantly increases costs and the reaction product contains free enzyme which is not desirable from the viewpoint of further product use.
  • nanofibers are a particularly suitable substrate because their specific surface is in units to tens of m 2 /g while they keep suitable mechanical properties; those properties make it possible to form shapeable nanofiber layers that may be easily placed into a wound or into a holder in a biochemical reactor and after completion of the application they may be ⁇ removed.
  • patents CZ 294274 or WO 2005024101 describe a method of nanofiber preparation by electrostatic spinning. However, the patents CZ 294274 or WO 2005024101 , do not specify in detail polymer solutions for preparation of the nanofibers.
  • methyltrimethoxysilane is used as a precursor to prepare silica nanofibers.
  • the nanofibers will have hydrophobic properties as a result of presence of methyl groups on the surface and the number of Si-OH groups on the surface for its subsequent potential modification with aminoalkylalkoxysilane will be low. For this reason the procedure under WO 2009018104 is not suitable for preparation of initial silica nanofibers for the subsequent stages of modification and immobilization of organic agens.
  • JP20040041335, JP20040161234 and JP20040243580 describe preparation of an organic-inorganic nanofiber composite made of a regular framework of polyethylene imide fibers with layers of silicon dioxide applied with a sol-gel method.
  • the resulting composite material is intended to trap, or to increase concentrations of, various substances in the prepared structure, however, only as a filter, i.e. in gaps between individual nanofibers, or by simple adsorption of the desired particles in the bulk nanofiber composite.
  • the packaging paper under the patent KR20090058155 is made of nanofibers obtained by electrostatic spinning of a biodegradable organic polymer with addition of sol of silicon dioxide and silver nitrate.
  • the resulting product has antiseptic and antibacterial properties but it is not suitable for immobilization of organic agens.
  • the patent KR20100058372 describes preparation of a catalyst from mesoporous nanofibers of silicon dioxide prepared by growing from a gaseous phase and subsequent introduction of a catalyst with silane on the surface and into the pores of the nanofibers prepared in this manner.
  • the resulting product is described as a catalyst of various organic reactions and it is not used for immobilization of organic agens.
  • the drawback of the existing state of technology consists in the absence of a sufficiently biochemically stable structure capable of sufficiently high, efficient and, in terms of time, stable immobilization of organic agens.
  • the objective of this invention is to eliminate, or at least to minimize, disadvantages of the current state of technology.
  • the objective of the invention is achieved by a nanofiber structure with immobilized organic agens, the principle of which consists in the fact that silica nanofibers have their surface modified by a reaction with aminoalkylalkoxysilane and subsequently organic agens is immobilized on their surface with peptide or hydrogen bonds.
  • Silica nanofibers are suitable particularly thanks to their high stability in biochemical reactions and thanks to their dissolving ability in body fluids.
  • the dissolving rate of silica nanofibers is controlled by the temperature of thermal processing of the silica nanofibers and therefore the nanofibers may be removed from the wound along with the immobilized agens after a previously specified time and the residues of silica nanofibers potentially released in the place of application, in a wound or bioreactor, e.g. by breaking etc., are then dissolved in body fluids or in the bioreactor sufficiently quickly without any negative side effects.
  • Silica nanofibers have another advantage that their surface with high numbers of Si-OH groups can be easily modified with reactions in which Si-OH groups are linked via covalent bonds with aminoalkylalkoxysilanes whose amino groups subsequently enable formation of relatively strong peptide bonds or slightly weaker hydrogen bonds with the immobilized organic agens.
  • the principle of the method of preparation of the nanofiber structure with immobilized organic agens consist in preparation of an initial sol from tetraalkoxysilane using a sol-gel method and the sol is then exposed to electrostatic spinning; the resulting nanofiber structure is heat-treated and its surface is treated with aminoalkylalkoxysilane; the surface of the nanofiber structure is then exposed to a solution organic agens and the organic agens is immobilized by means of peptide or hydrogen bonds on the surface of the nanofiber structure.
  • the basis of this method is to create a nanofiber structure, e.g. in form of silica nanofibers made by electrostatic spinning from a sol prepared by a sol-gel method from tetraalkoxysilane using acidic catalysis and without additional organic polymers.
  • This method can be used to prepare silica nanofibers with the average diameter in the range 100 to 1000 nm (depending on the conditions of preparation of the initial sol and the conditions of electrostatic spinning) to form a nanofiber structure (layer) that can be directly used for subsequent operations, without the necessity to remove any additives by heat treatment at high temperatures.
  • Specific surfaces of nanofiber structures (layers) prepared in this manner range from units to tens of m 2 /g and thus they ensure large surfaces for immobilization of organic agens even if the nanofiber layer is thin.
  • the resulting properties of the nanofiber structure e.g. the number of active Si-OH groups for subsequent bonds with aminoalkylalkoxysilane and chemical durability against water and body fluids, are fundamentally affected by a sufficient heat treatment of the nanofiber layer before immobilization of organic agens.
  • the morphology of nanofibers practically does not change up to the temperature around 850 °C, when it transforms into silica glass (except a slight reduction of their diameters as a result of their thickened structure at high temperatures).
  • silica nanofibers gradually reduce their chemical solubility and the number of active Si-OH groups for subsequent bonds with aminoalkylalkoxysilane.
  • the surface of nanofibers is therefore modified by a solution of aminoalkylalkoxysilane which forms covalent bonds, by polycondensation via alkoxy groups, with surface Si- OH groups of silica nanofibers and with its free aminoalkyl group provides a primary functional amino group for the formation of peptide or hydrogen bonds with organic agens.
  • a suitable solvent or environment water, alcohol or other organic solution
  • the immobilization of organic agens on the surface of silica nanofibers with the surface modified according to this invention is sufficiently strong to ensure that during the subsequent application of the nanofiber structure with immobilized organic agens, e.g.
  • the immobilized organic agens operates but it is not released from the nanofiber structure or is released only in small quantities, i.e. only in minimum quantities This ensures a long-term, contact and high concentration of organic agens at a place of their desired application, without being washed away and without excessive release from the place of application.
  • the prepared sol was used for electrostatic spinning at the voltage of 50 kV and the distance of 15 cm.
  • the average size of the prepared nanofibers was 180 nm.
  • the resulting nanofiber structure in from of a layer of nanofibers was heat-treated at 180 °C for 2 hours in a drying kiln and the surface of silica nanofibers was modified by immersion into a 2% solution of 3- aminopropyltriethoxysilane in anhydrous ethanol for 1 hour at the laboratory temperature.
  • the modified nanofiber structure was washed three times with anhydrous ethanol and submerged into 2% solution of tetracycline or penicillin in anhydrous ethanol for 2 hours at the laboratory temperature.
  • the nanofiber structure with the immobilized antibiotic (organic agens) was flushed twice with anhydrous ethanol and left to dry in a desiccator.
  • the function of the nanofiber structure with the immobilized antibiotic was verified by antibacterial tests on a selected group of pathogenic bacterial strains that may cause problems particularly in dermatology. They included bacterial strains Staphylococcus aureus, RSA, Escherichia coli, Klebsiella pneumoniae, Proteus vulgaris, Proteus mirabilis and Pseudomonas aeruginosa. Samples of the nanofiber structure with the immobilized antibiotic were placed into a center of a Petri dish with respective bacterial inoculum of a selected bacterial strain. The samples were incubated in a thermostat for 24 hours at 37 °C. Further, the size of the so-called halo zones was evaluated (i.e. zones around the nanofiber structure with immobilized antibiotics).
  • the prepared sol was used for electrostatic spinning at the voltage of 50 kV and the distance of 15 cm.
  • the average size of the prepared nanofibers was 580 nm.
  • the resulting nanofiber structure was in from of a layer of nanofibers was heat-treated at 180 °C for 2 hours in a drying kiln and the surface of nanofibers was subsequently modified with a 2% solution of 3- aminopropyltrimethoxysiiane in distilled water for 1 hour at the laboratory temperature.
  • the immobilization of the enzymes on the nanofiber structure was verified with a histochemical azocopulation reaction of alpha-naphtyl acetate and chromogenic dye with the enzyme.
  • the solution of alpha-naphtyl acetate and Fast Blue BB dye in phosphate buffer in combination with the enzyme formed colored deposits of immobilized enzyme that were visible in a microscope and demonstrated its presence.
  • the tests were performed as comparative against a nanofiber structure made of silica nanofibers on which no enzyme was immobilized hereunder, while no deposits as described above were found on the control nanofiber structure without the enzymes.

Abstract

The invention concerns a nanofiber structure with immobilized organic agens that consists of silica nanofibers whose surface was modified with aminoaikyialkoxysilane and of subsequently immobilized organic agens. The invention also concerns a method of preparation of the nanofiber structure with immobilized organic agens, while silica nanofibers are prepared by electrostatic spinning from the initial sol synthesized by a sol-gel method from tetraalkoxysilane, heat-treated and their the surface modified by a solution of aminoaikyialkoxysilane and organic agens is then immobilized on the modified surface of the nanofibers.

Description

Nanofiber structure with immobilized organic agens and the method of its preparation
Technology area The invention concerns a nanofiber structure with immobiiized organic agens.
The invention also concerns a method of preparation of the nanofiber structure with immobilized organic agens.
Existing state of technology
In many medicine and biotechnology applications functional organic agens (medicines, enzymes etc.) is applied by being placed into the respective environment where they should operate, i.e. into wounds, or biochemical reactors etc.. Sometimes the functional organic agens need to be significantly overdosed because there are significant losses of the agens due to dispersion or washing away (typically washing of antibiotics from the wound etc.) or it is necessary to administer the agens frequently. This, however, may cause permeation of the agens into other parts of the organism and undesired side effects or, on the contrary, insufficient efficiency of the applied agens.
In biochemical applications the employed organic agens (mostly enzymes) usually cannot be recovered from the application area, e.g. for further use, and a new quantity of the functional organic agens needs to be added into the next production batch. This, however, significantly increases costs and the reaction product contains free enzyme which is not desirable from the viewpoint of further product use.
These problems may be eliminated or limited by immobilization of organic agens on suitable substrates, i.e. ideally by permanent or at least as long as possible lasting attachment of organic agens on suitable carriers. The preconditions of this approach include, apart from a sufficiently stable immobilization of the organic agens on the substrate, keeping of the efficiency and function of the agens and also a sufficient quantity of the immobilized agens.
The quantity of the immobilized agens depends on the number of suitable bonding places for immobilization and on the specific surface of the substrate. From this point of view nanofibers are a particularly suitable substrate because their specific surface is in units to tens of m2/g while they keep suitable mechanical properties; those properties make it possible to form shapeable nanofiber layers that may be easily placed into a wound or into a holder in a biochemical reactor and after completion of the application they may be · removed.
The patents CZ 294274 or WO 2005024101 describe a method of nanofiber preparation by electrostatic spinning. However, the patents CZ 294274 or WO 2005024101 , do not specify in detail polymer solutions for preparation of the nanofibers.
In the patent WO20090 8104 methyltrimethoxysilane is used as a precursor to prepare silica nanofibers. Without heat treatment according to WO20090 8104 or if heat-treated at low temperatures according to WO2009018104, the nanofibers will have hydrophobic properties as a result of presence of methyl groups on the surface and the number of Si-OH groups on the surface for its subsequent potential modification with aminoalkylalkoxysilane will be low. For this reason the procedure under WO 2009018104 is not suitable for preparation of initial silica nanofibers for the subsequent stages of modification and immobilization of organic agens.
The patents JP20040041335, JP20040161234 and JP20040243580 describe preparation of an organic-inorganic nanofiber composite made of a regular framework of polyethylene imide fibers with layers of silicon dioxide applied with a sol-gel method. The resulting composite material is intended to trap, or to increase concentrations of, various substances in the prepared structure, however, only as a filter, i.e. in gaps between individual nanofibers, or by simple adsorption of the desired particles in the bulk nanofiber composite.
The packaging paper under the patent KR20090058155 is made of nanofibers obtained by electrostatic spinning of a biodegradable organic polymer with addition of sol of silicon dioxide and silver nitrate. The resulting product has antiseptic and antibacterial properties but it is not suitable for immobilization of organic agens.
The patent KR20100058372 describes preparation of a catalyst from mesoporous nanofibers of silicon dioxide prepared by growing from a gaseous phase and subsequent introduction of a catalyst with silane on the surface and into the pores of the nanofibers prepared in this manner. The resulting product is described as a catalyst of various organic reactions and it is not used for immobilization of organic agens.
The drawback of the existing state of technology consists in the absence of a sufficiently biochemically stable structure capable of sufficiently high, efficient and, in terms of time, stable immobilization of organic agens.
The objective of this invention is to eliminate, or at least to minimize, disadvantages of the current state of technology.
Principle of the invention
The objective of the invention is achieved by a nanofiber structure with immobilized organic agens, the principle of which consists in the fact that silica nanofibers have their surface modified by a reaction with aminoalkylalkoxysilane and subsequently organic agens is immobilized on their surface with peptide or hydrogen bonds.
Silica nanofibers are suitable particularly thanks to their high stability in biochemical reactions and thanks to their dissolving ability in body fluids. The dissolving rate of silica nanofibers is controlled by the temperature of thermal processing of the silica nanofibers and therefore the nanofibers may be removed from the wound along with the immobilized agens after a previously specified time and the residues of silica nanofibers potentially released in the place of application, in a wound or bioreactor, e.g. by breaking etc., are then dissolved in body fluids or in the bioreactor sufficiently quickly without any negative side effects. Silica nanofibers have another advantage that their surface with high numbers of Si-OH groups can be easily modified with reactions in which Si-OH groups are linked via covalent bonds with aminoalkylalkoxysilanes whose amino groups subsequently enable formation of relatively strong peptide bonds or slightly weaker hydrogen bonds with the immobilized organic agens.
The principle of the method of preparation of the nanofiber structure with immobilized organic agens consist in preparation of an initial sol from tetraalkoxysilane using a sol-gel method and the sol is then exposed to electrostatic spinning; the resulting nanofiber structure is heat-treated and its surface is treated with aminoalkylalkoxysilane; the surface of the nanofiber structure is then exposed to a solution organic agens and the organic agens is immobilized by means of peptide or hydrogen bonds on the surface of the nanofiber structure.
The basis of this method is to create a nanofiber structure, e.g. in form of silica nanofibers made by electrostatic spinning from a sol prepared by a sol-gel method from tetraalkoxysilane using acidic catalysis and without additional organic polymers. In order to obtain a sol with suitable properties for electrostatic spinning it is necessary to observe the molar ratio of water to tetraalkoxysilane k = [H20]/[tetraalkoxysilane] in the range k = 1.6 to 3, the molar ratio of acid to tetraalkoxysilane m = [HA]/[tetraalkoxysilane] in the rage m = 0.001 to 1 and the sol shall be concentrated before spinning by evaporation of the solvent to achieve the S1O2 concentration in the sol in the range 28 to 44 wt. %.
This method can be used to prepare silica nanofibers with the average diameter in the range 100 to 1000 nm (depending on the conditions of preparation of the initial sol and the conditions of electrostatic spinning) to form a nanofiber structure (layer) that can be directly used for subsequent operations, without the necessity to remove any additives by heat treatment at high temperatures. Specific surfaces of nanofiber structures (layers) prepared in this manner range from units to tens of m2/g and thus they ensure large surfaces for immobilization of organic agens even if the nanofiber layer is thin.
The resulting properties of the nanofiber structure, e.g. the number of active Si-OH groups for subsequent bonds with aminoalkylalkoxysilane and chemical durability against water and body fluids, are fundamentally affected by a sufficient heat treatment of the nanofiber layer before immobilization of organic agens. The morphology of nanofibers practically does not change up to the temperature around 850 °C, when it transforms into silica glass (except a slight reduction of their diameters as a result of their thickened structure at high temperatures). During the heat treatment silica nanofibers gradually reduce their chemical solubility and the number of active Si-OH groups for subsequent bonds with aminoalkylalkoxysilane. Sufficient chemical solubility of silica nanofibers in body fluids is necessary because the size of nanofiber fragments released during manipulation with the nanofiber structure and their accidental inhalation is in the area of documented carcinogenity in case of their long-term local presence (more than 40 days). During dynamic and static tests of silica nanofibers dissolving (average diameter around 180 nm) in simulated lung fluid the dissolving rate of nanofibers was strongly dependent on the temperature of thermal processing of the nanofibers. In case of heat treatment at low temperatures (180 °C/2 hours) the nanofibers dissolved within 7 days and they can be considered safe for manipulation and in case of accidental inhalation. However, in case of heat treatment at higher temperatures the nanofibers gradually became less soluble and the nanofibers heat-treated in this manner shall be viewed as potentially carcinogenic.
Most of medically of biochemically active organic agens contain carboxyl (-COOH) or at least hydroxyl (-COH) groups. However, to ensure a sufficient level and reliability of immobilization of such organic agens on the surface of silica nanofibers it is necessary to modify the surface of the nanofibers so that there are firmly bound amino groups on it to form peptide bonds with carboxyl groups or hydrogen bonds with hydroxyl groups. In this manner the organic agens is sufficiently immobilized on the surface of nanofibers. The surface of nanofibers is therefore modified by a solution of aminoalkylalkoxysilane which forms covalent bonds, by polycondensation via alkoxy groups, with surface Si- OH groups of silica nanofibers and with its free aminoalkyl group provides a primary functional amino group for the formation of peptide or hydrogen bonds with organic agens. In a suitable solvent or environment (water, alcohol or other organic solution) the formation of bonds between amino groups and organic agens is spontaneous. The immobilization of organic agens on the surface of silica nanofibers with the surface modified according to this invention is sufficiently strong to ensure that during the subsequent application of the nanofiber structure with immobilized organic agens, e.g. in presence of water or body fluids, like in open wounds etc., the immobilized organic agens operates but it is not released from the nanofiber structure or is released only in small quantities, i.e. only in minimum quantities This ensures a long-term, contact and high concentration of organic agens at a place of their desired application, without being washed away and without excessive release from the place of application.
Examples of execution of the invention
The invention will be described on examples of the procedures to prepare nanofiber structure in form of a layer of silica nanofibers with modified surface and immobilized organic agens on the surface. In the following text the invention is documented with specific examples which, however, do not document all possibilities of the invention whose application and use are obvious to an average expert from this text without any additional inventing efforts.
Example 1
The initial sol for preparation of silica nanofibers was prepared with a modified sol-gel method. 400 ml of tetraethoxysilane were dissolved in 330 ml isopropyl alcohol and water and HCI were added to achieve the molar ratio k = [H20]/[tetraalkoxysilane] = 2.3 and the molar ratio m = [HCI]/[tetraalkoxysilane] = 0.01. After completion of hydrolytic and polycondensation reactions the sol was concentrated by evaporation of the solvent to 36 wt. % of Si02.
The prepared sol was used for electrostatic spinning at the voltage of 50 kV and the distance of 15 cm. The average size of the prepared nanofibers was 180 nm. The resulting nanofiber structure in from of a layer of nanofibers was heat-treated at 180 °C for 2 hours in a drying kiln and the surface of silica nanofibers was modified by immersion into a 2% solution of 3- aminopropyltriethoxysilane in anhydrous ethanol for 1 hour at the laboratory temperature. The modified nanofiber structure was washed three times with anhydrous ethanol and submerged into 2% solution of tetracycline or penicillin in anhydrous ethanol for 2 hours at the laboratory temperature. Finally, the nanofiber structure with the immobilized antibiotic (organic agens) was flushed twice with anhydrous ethanol and left to dry in a desiccator.
The function of the nanofiber structure with the immobilized antibiotic was verified by antibacterial tests on a selected group of pathogenic bacterial strains that may cause problems particularly in dermatology. They included bacterial strains Staphylococcus aureus, RSA, Escherichia coli, Klebsiella pneumoniae, Proteus vulgaris, Proteus mirabilis and Pseudomonas aeruginosa. Samples of the nanofiber structure with the immobilized antibiotic were placed into a center of a Petri dish with respective bacterial inoculum of a selected bacterial strain. The samples were incubated in a thermostat for 24 hours at 37 °C. Further, the size of the so-called halo zones was evaluated (i.e. zones around the nanofiber structure with immobilized antibiotics).
Results of the antibacterial tests were excellent - the sizes of tested halo zones were evaluated as 100% inhibition ability of the antibiotics against the selected bacterial pathogenic strains. This has confirmed that both the antibiotics were immobilized on the nanofiber structure of silica nanofibers with modified surface hereunder, without losing their function.
Example 2
The initial sol for preparation of silica nanofibers was prepared by a modified sol-gel method. 400 ml of tetraethoxysilane were dissolved in 330 ml isopropyl alcohol and water and HCI were added to achieve the molar ratio k = [H20]/[tetraalkoxysilane] = 2.0 and the molar ratio m = [HCI]/[tetraalkoxysilane] = 0.01. After completion of hydrolytic and polycondensation reactions the sol was concentrated by evaporation of the solvent to 40 wt. % of S1O2.
The prepared sol was used for electrostatic spinning at the voltage of 50 kV and the distance of 15 cm. The average size of the prepared nanofibers was 580 nm. The resulting nanofiber structure was in from of a layer of nanofibers was heat-treated at 180 °C for 2 hours in a drying kiln and the surface of nanofibers was subsequently modified with a 2% solution of 3- aminopropyltrimethoxysiiane in distilled water for 1 hour at the laboratory temperature. The nanofiber structure with the modified surface was washed three times with distilled water and once with a solution of phosphate buffer (pH = 7.2) and then it was submerged into a 2% solution of esterase or lipase enzyme in phosphate buffer for 10 minutes at the laboratory temperature. Finally, the nanofiber layer with the immobilized enzyme was flushed two times with phosphate buffer and left to dry in the laboratory environment.
The immobilization of the enzymes on the nanofiber structure was verified with a histochemical azocopulation reaction of alpha-naphtyl acetate and chromogenic dye with the enzyme. The solution of alpha-naphtyl acetate and Fast Blue BB dye in phosphate buffer in combination with the enzyme formed colored deposits of immobilized enzyme that were visible in a microscope and demonstrated its presence. The tests were performed as comparative against a nanofiber structure made of silica nanofibers on which no enzyme was immobilized hereunder, while no deposits as described above were found on the control nanofiber structure without the enzymes.

Claims

PATENT CLAIMS
1. A nanofiber structure with immobilized organic agens characterized by the fact that it consists of silica nanofibers whose surface was modified with aminoalkylalkoxysilane and of subsequently immobilized organic agens.
2. A method of preparation of the nanofiber structure with immobilized organic agens characterized by the fact that the silica nanofibers are prepared by electrostatic spinning from the initial sol synthesized by a sol-gel method from tetraalkoxysilane, heat-treated and its surface is modified with a solution of aminoalkylalkoxysilane and organic agens is subsequently immobilized on the modified surface of the nanofibers.
3. A method under the claim 2 characterized by the fact that the initial sol is prepared by a sol-gel method from a solution of tetraalkoxysilane in alcohol with an addition of water, using acidic catalysis of controlled hydrolysis and polycondensation, and the product is concentrated by distilling off the solvent to increase its concentration and to achieve the viscosity necessary for electrostatic spinning.
4. A method under the claim 3 characterized by the fact that the employed alcohol is ethanol or isopropyl alcohol, the acidic catalysis of the hydrolysis and polycondensation of tetraalkoxysilane is ensured by addition of an inorganic or organic acid, the initial molar ratio of water to tetraalkoxysilane k = [H20]/[tetraalkoxysilane] ranges from 1.6 to 3, the molar ratio of the acid to tetraalkoxysilane m = [HA]/[tetraalkoxysilane] ranges from 0.001 to 1 and the sol before the spinning is concentrated by evaporation of the solvent to the concentration of Si02 in the sol ranging from 28 to 44 wt. %.
5. A method under the claim 4 characterized by the fact that the tetraalkoxysilane is tetraethoxysilane and the acid is hydrochloric acid or nitric acid.
6. A method under the claim 2 characterized by the fact that silica nanofibers with the average diameter 100 to 1000 nm prepared by electrostatic spinning are subsequently heat-treated in the temperature range from 30 to 900 °C for a period from 10 minutes to 10 hours.
7. A method under the claim 6 characterized by the fact that the silica nanofibers are heat-treated in the temperature range from 150 ° C to 250 °C for 1 to 3 hours.
8. A method under the claim 2 characterized by the fact that the aminoalkylalkoxysiiane solution is dissolved in water, alcohol or another organic solvent and its concentration is from 0.1 to 10 wt. %.
9. A method under the claim 8 characterized by the fact that the aminoalkylalkoxysiiane is 3-aminopropyltriethoxysilane or 3- aminopropyltrimethoxysilane.
10. A method under the claim 2 characterized by the fact that the immobilization of organic agens on the modified surface of nanofibers is performed in a liquid environment, for a period from 30 seconds to 48 hours.
1 . A method under the claim 10 characterized by the fact that the liquid environment is water, water solution of a biochemical buffer, ethanol, isopropyl alcohol or acetone and the immobilization time ranges from 3 minutes to 24 hours.
PCT/CZ2012/000128 2012-08-14 2012-12-10 Nanofiber structure with immobilized organic agens and the method of its preparation WO2014026656A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP12818872.9A EP2884968A1 (en) 2012-08-14 2012-12-10 Nanofiber structure with immobilized organic agens and the method of its preparation
US14/421,256 US20150240411A1 (en) 2012-08-14 2012-12-10 Nanofiber structure with immobilized organic substance and the method of its preparation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZPV2012-549 2012-08-14
CZ20120549A CZ2012549A3 (en) 2012-08-14 2012-08-14 Nanofibrous structure with immobilized organic agent and process for preparing thereof

Publications (2)

Publication Number Publication Date
WO2014026656A1 true WO2014026656A1 (en) 2014-02-20
WO2014026656A8 WO2014026656A8 (en) 2014-04-17

Family

ID=47605254

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CZ2012/000128 WO2014026656A1 (en) 2012-08-14 2012-12-10 Nanofiber structure with immobilized organic agens and the method of its preparation

Country Status (4)

Country Link
US (1) US20150240411A1 (en)
EP (1) EP2884968A1 (en)
CZ (1) CZ2012549A3 (en)
WO (1) WO2014026656A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023061520A1 (en) * 2021-10-14 2023-04-20 Technicka Univerzita V Liberci Biocompatible and biodegradable fibrous structure containing silica-based submicron fibers, biogenic ions and with a functional surface for binding active substances and a method of its production

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201720462A (en) * 2015-12-08 2017-06-16 昱程科技股份有限公司 Biological carrier comprising a base layer, a positioning target and a foot
CZ2016239A3 (en) * 2016-04-26 2017-06-28 Pardam, S.R.O. Precursor fibre intended for the preparation of silicon fibres, the method of its manufacture, the method of its modification and its use
WO2017186201A1 (en) 2016-04-26 2017-11-02 Pardam, S.R.O. Precursor fibers intended for preparation of silica fibers, method of manufacture thereof, method of modification thereof, use of silica fibers
CN107383401B (en) * 2017-07-03 2020-10-27 苏州宏久航空防热材料科技有限公司 Preparation method of antibacterial NCC film with surface grafted with sulfonamide group
CA3095574A1 (en) * 2018-04-02 2019-10-10 American Nano, LLC Topical compositions incorporating silica fibers
EP3617173A1 (en) 2018-12-14 2020-03-04 Fyzikální ústav AV CR, v.v.i. Use of a layer for surface protection and/or preservation of a tangible cultural heritage
CN113061596B (en) * 2021-03-29 2023-07-14 万华化学集团股份有限公司 Immobilized enzyme catalyst, preparation method thereof and application thereof in synthesis of vitamin A palmitate
EP4166699A1 (en) * 2021-10-14 2023-04-19 Technicka univerzita v Liberci Biocompatible and biodegradable fibrous structure containing silica-based submicron fibers, biogenic ions and with a functional surface for binding active substances and a method of its production

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004041335A (en) 2002-07-10 2004-02-12 Nidek Co Ltd Laser treatment apparatus for ophthalmology
JP2004161234A (en) 2002-02-13 2004-06-10 Soc De Technol Michelin Device to fix tire monitor device module to wheel
JP2004243580A (en) 2003-02-12 2004-09-02 Nippon Steel Corp Method for manufacturing embossed resin film-coated metal sheet
CZ294274B6 (en) 2003-09-08 2004-11-10 Technická univerzita v Liberci Process for producing nanofibers from polymeric solution by electrostatic spinning and apparatus for making the same
CN101165083A (en) * 2006-10-16 2008-04-23 中国科学院化学研究所 Ultra-hydrophobic polystyrene thin film enhanced by nano silicon dioxide particles and preparation method thereof
WO2009018104A2 (en) 2007-07-27 2009-02-05 Dow Corning Corporation Fiber structure and method of making same
KR20090058155A (en) 2007-12-04 2009-06-09 주식회사 에이엠오 Packing paper using the nanofibers of functional subjoin
KR20100058372A (en) 2008-11-24 2010-06-03 서울대학교산학협력단 Catalytic application of mesoporous silica nanofiber in aao membrane and control of their catalytic activity by tuning the mesostructure of mesoporous nanofiber
US20110274927A1 (en) * 2009-01-14 2011-11-10 Rie Watanabe Inorganic fiber structure and process for producing same

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004161234A (en) 2002-02-13 2004-06-10 Soc De Technol Michelin Device to fix tire monitor device module to wheel
JP2004041335A (en) 2002-07-10 2004-02-12 Nidek Co Ltd Laser treatment apparatus for ophthalmology
JP2004243580A (en) 2003-02-12 2004-09-02 Nippon Steel Corp Method for manufacturing embossed resin film-coated metal sheet
CZ294274B6 (en) 2003-09-08 2004-11-10 Technická univerzita v Liberci Process for producing nanofibers from polymeric solution by electrostatic spinning and apparatus for making the same
WO2005024101A1 (en) 2003-09-08 2005-03-17 Technicka Univerzita V Liberci A method of nanofibres production from a polymer solution using electrostatic spinning and a device for carrying out the method
CN101165083A (en) * 2006-10-16 2008-04-23 中国科学院化学研究所 Ultra-hydrophobic polystyrene thin film enhanced by nano silicon dioxide particles and preparation method thereof
WO2009018104A2 (en) 2007-07-27 2009-02-05 Dow Corning Corporation Fiber structure and method of making same
KR20090058155A (en) 2007-12-04 2009-06-09 주식회사 에이엠오 Packing paper using the nanofibers of functional subjoin
KR20100058372A (en) 2008-11-24 2010-06-03 서울대학교산학협력단 Catalytic application of mesoporous silica nanofiber in aao membrane and control of their catalytic activity by tuning the mesostructure of mesoporous nanofiber
US20110274927A1 (en) * 2009-01-14 2011-11-10 Rie Watanabe Inorganic fiber structure and process for producing same

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
C.-C.- CHEN, Y.-C. LIU, C.-H. WU, C.-C. YEH, M.-T. SU, Y.-C. WU: "Preparation of fluorescent silica nanotubes and their application in gene delivery", ADV. MATER., vol. 17, no. 4, 23 February 2005 (2005-02-23), Weinheim, pages 404 - 407, XP002694565, DOI: 10.1002/adma.200400966 *
HU K W ET AL: "pH-Dependent biodegradable silica nanotubes derived from Gd(OH)3 nanorods and their potential for oral drug delivery and MR imaging", BIOMATERIALS, ELSEVIER SCIENCE PUBLISHERS BV., BARKING, GB, vol. 31, no. 26, 1 September 2010 (2010-09-01), pages 6843 - 6848, XP027132792, ISSN: 0142-9612, [retrieved on 20100612] *
JAFAR EZZATI NAZHAD DOLATABADI: "Applications of diatoms and silica nanotechnology in biosensing, drug and gene delivery, and formation of complex metal nanostructures", TRAC, TRENDS IN ANALYTICAL CHEMISTRY, vol. 30, no. 9, 4 August 2011 (2011-08-04), pages 1538 - 1548, XP028285500, ISSN: 0165-9936, [retrieved on 20110804], DOI: 10.1016/J.TRAC.2011.04.015 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023061520A1 (en) * 2021-10-14 2023-04-20 Technicka Univerzita V Liberci Biocompatible and biodegradable fibrous structure containing silica-based submicron fibers, biogenic ions and with a functional surface for binding active substances and a method of its production

Also Published As

Publication number Publication date
CZ303911B6 (en) 2013-06-19
CZ2012549A3 (en) 2013-06-19
US20150240411A1 (en) 2015-08-27
EP2884968A1 (en) 2015-06-24
WO2014026656A8 (en) 2014-04-17

Similar Documents

Publication Publication Date Title
WO2014026656A1 (en) Nanofiber structure with immobilized organic agens and the method of its preparation
Kurczewska et al. Halloysite nanotubes as carriers of vancomycin in alginate-based wound dressing
Zhang et al. Protamine-templated biomimetic hybrid capsules: efficient and stable carrier for enzyme encapsulation
Bryaskova et al. Synthesis, characterisation and antibacterial activity of PVA/TEOS/Ag-Np hybrid thin films
Asker et al. Non-eluting, surface-bound enzymes disrupt surface attachment of bacteria by continuous biofilm polysaccharide degradation
Zhu et al. Slippery liquid-like solid surfaces with promising antibiofilm performance under both static and flow conditions
Moradi et al. Preparation and characterization of chitosan based hydrogels containing cyclodextrin inclusion compounds or nanoemulsions of thyme oil
Tian et al. Antibacterial applications and safety issues of silica‐based materials: A review
Mutlu et al. Silicon alkoxide cross-linked silica nanoparticle gels for encapsulation of bacterial biocatalysts
CN112646197B (en) Aminated lignin and preparation method and application thereof
CN105475359B (en) Application of lysozyme two-dimensional nano-film as antibacterial material
Jiang et al. Self-assembled DNA-THPS hydrogel as a topical antibacterial agent for wound healing
CN112359071A (en) Water-soluble controllable antibacterial substance and synthesis process thereof
CN109106977A (en) A kind of self-healing injection aquagel dressing and the preparation method and application thereof for Tissue of Diabetic Wound reparation
Colilla et al. Amino− Polysiloxane Hybrid Materials for Bone Reconstruction
Han et al. Activity of glucose oxidase entrapped in mesoporous gels
Li et al. Rapid preparation and antimicrobial activity of polyurea coatings with RE‐Doped nano‐ZnO
Kaya et al. Aerogels as promising materials for antibacterial applications: A mini-review
Hu et al. A Smart Hydrogel with Anti‐Biofilm and Anti‐Virulence Activities to Treat Pseudomonas aeruginosa Infections
WO2011095353A1 (en) Active antimicrobial compositions, coatings and methods for controlling pathogenic bacteria
Ferreres et al. Nanomaterials and coatings for managing antibiotic-resistant biofilms
TW200838570A (en) Chromatographic media and chromatographic equipment storage solutions and use thereof
Andreeva et al. Novel type of self-assembled polyamide and polyimide nanoengineered shells fabrication of microcontainers with shielding properties
CN114569582A (en) Enzyme preparation, preparation method and application thereof
CN101659773A (en) Nano TiO2-polystyrene microsphere compound and preparation method and application thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12818872

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 14421256

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2012818872

Country of ref document: EP